Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7853	GSK2801 Featured	GSK2801 is a very potent inhibitor of the BAZ2 family of bromodomain containing proteins.
DC9719	Lp-PLA2 -IN-1(GSK2814338) Featured	GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor
DC7847	HIV Inhibitor GSK2838232 Featured	GSK2838232 is a novel human immune virus (HIV) maturation inhibitor being developed for the treatment of chronic HIV infection.
DC22317	GSK-2894631A(HPGDS inhibitor 2) Featured	GSK-2894631A,GSK 2894631A，GSK2894631A
DC9717	amyloid P-IN-1(GSK3039294) Featured	GSK3039294 is a Serum amyloid P component inhibitor.
DC26011	GSK3145095 Featured	GSK3145095 is an orally available, small-molecule inhibitor of RIPK1, with potential antineoplastic and immunomodulatory activities.
DC8505	GSK369796 Featured	GSK369796 shows antimalerial activity with IC50 values of 11.2 nM for 3D7 strain, 12.6 nM for HB3 strain, 17.6 nM for K1 strain
DC22306	cGAS inhibitor 467 Featured	GSK467 is a potent and selective inhibitor of KDM5 (also known as JARID1). GSK467 exploits unique binding modes.
DC12513	RIP1 inhibitor GSK547 Featured	GSK547 (RIP1i, GSK 547) is a highly selective and potent inhibitor of RIP1 kinase that robustly targets RIP1 in vivo.
DC8373	GSK8573 Featured	GSK-8573 is the inactive control of GSK-2801.
DC26130	GSK8612 Featured	GSK8612 is a highly selective and potent Tank-binding Kinase-1 (TBK1) inhibitor, with a pIC50 of 6.8 for recombinant TBK1.
DC9907	GSK9311 Featured	GSK9311 is a potent and highly selective inhibitor of the BRPF bromodomain (BRPDF1 pIC50 = 6.0; BRPDF2 pIC50 = 4.3).
DC10064	GSK-F1 Featured	GSK-F1 is a potent inhibitor of PI4KA.
DC7858	GSK-J1 Featured	GSK-J1 is a potent and selective inhibitor of the H3K27 histone demethylases JMJD3 and UTX (IC50 = 60 nM for human JMJD3 in vitro).
DC7857	GSK-LSD1 Featured	GSK-LSD1 is a potent and selective inhibitor of lysine specific demethylase 1 (LSD1).
DC23890	GSM-1	GSM-1 (GSM1) is a γ-secretase modulator that directly targets the transmembrane domain (TMD) 1 of presenilin 1, shows potent Aβ42-lowering effect (IC50=0.348 uM) in a cell-based assay.
DC23886	GSM-2	GSM-2 is a second-generation γ-secretase modulator (GSM) that only decreases Aβ42 (IC50=65.2 nM), while inversely increasing Aβ38 and having no effect on β-CTF and Aβ40 levels.
DC20399	GSTO1 inhibitor C1-27	GSTO1 inhibitor C1-27 is a potent, selective, covalent glutathione S-transferase omega 1 (GSTO1) inhibitor with IC50 of 31 nM.
DC20112	GT 949 Featured	GT 949 is a selective excitatory amino acid transporter-2 (EAAT2) positive allosteric modulator with an EC50 of 0.26 nM.
DC21403	GTC 365	GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters.
DC21404	GTC 365 hydrochloride	GTC-365 (NSC 177365) is a small drug-like pharmacological chaperone that induces cancer cell death by restoring tertiary DNA structures in mutant human telomerase reverse transcriptase (hTERT) promoters.
DCAPI1387	Guaifenesin(Guaiphenesin)	Guaifenesin(Guaiphenesin)
DC21825	Guanabenz Featured	Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent, also has been proposed to exert protective effects against misfolding by interfering with eIF2α-P dephosphorylation through selective disruption of a PP1-P
DC12076	Guanidinosuccinic acid	Guanidinosuccinic acid is a nitrogenous metabolite isolated in excess from serum and urine.
DC23297	GUT-70	GUT-70 is a tricyclic coumarin derived from Calophyllum brasiliense, markedly reduces cell proliferation, viability through G1 cell cycle arrest and increases apoptosis.
DC23117	GV-58	GV-58 is a potent, selective N-Type and P/Q-type Ca2+ Channel agonist with EC50 of 7.2 and 8.8 uM, shows no acitivity for L-type calcium channels (EC50>100 uM).
DC21102	GW 275175X	GW 275175X is a derivative of BDCRB that displays anti-HCMV activity by inhibition of viral DNA maturation.
DC23402	GW 841819X	GW 841819X is an analogue of (+)-JQ1 and a novel inhibitor of BET bromodomain that displays activity in vivo against NUT-midline carcinoma, multiple myeloma, mixed-lineage leukemia, and acute myeloid leukemia..
DC23142	GW274150 Featured	GW274150 is a novel arginine-competitive, NADPH-dependent iNOS inhibitor that has been identified from a series of acetamide amino acids that have a high selectivity for iNOS vs both eNOS (> 260-fold) and nNOS (> 219-fold) and high bioavailability (> 90%) after oral administration.Target: iNOSin vivo: GW274150 demonstrates a narrow neuroprotective therapeutic window against the toxic actions of 6-OHDA. GW274150 administration leads to a dose-dependent decrease in the number of iNOS-positive cells in the SNc of the 6-OHDA-lesioned animals. The iNOS inhibitor GW274150 fails to produce long-term neuroprotection after its withdrawal in the 6-OHDA-lesioned rat. [1]
DC8193	GW311616A	GW311616A is a potent, intracellular human neutrophil elastase (HNE, α-1-proteinase) inhibitor.

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.